Tropine 3 (“Homatropine”) is the novel new indication that Eaton recently acquired the Assigned rights to the Patent Pending application United States Office of Patent & Trademark No. 60/719,756. 

Tropine 3 is an orally ingested prescription product containing Homotropine that is intended to reduce climacteric symptoms and improve quality of life in menopausal women not receiving HRT (women who are experiencing “hot flashes” and “night sweats”).

Homatropine (Equipin, Isopto Homatropine) is an anticholinergic medication that inhibit muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic to temporarily paralyze accommodation, and as a mydriatic, to dilate the pupil.

For Homatropine methylbromide Methylhomatropine, this is a different medication. Homatropine is less potent than atropine and has a shorter duration of action. It is available as the hydrobromide salt. 

At Eaton Scientific we create
solutions for a better tomorrow.



Today's Mature Woman

Put the burdens of menoppause to rest.

Night sweats or sleep hyperhidrosis are conditions in which the body’s temperature monitoring system goes awry during menopause.

In fact more than 75% of women can experience NIGHT SWEATS, the night time HOT FLASH.

Eaton Scientific's TROPINE 3 has been tested sussessfully on patients suffering from sleep hyperhidrosis.

 

Homatropine is also given as an atropine substitute given to reverse the muscarinic and CNS effects associated with indirect cholinomimetic (anti-AChase) administration.

Homatropine is an anti-muscarinic which acts on the eye muscles to produce dilatation of the pupil (mydriasis), and prevents the eye from accommodating for near vision (cyclopegia).  This substance is typically used by an optometrist or ophthalmologist, to facilitate examination of the inside of a patient's eye.

SEE ALSO:

BACKGROUND OF HOMATROPINE INVEENTION
SUMMARY OF TROPINE 3

HOME | ABOUT US | MARKET | PRODUCTS | NEWS | CONTACT US